The effect of oral management on the severity of oral mucositis during hematopoietic SCT

Bone Marrow Transplantation

Volumn 47, Issue 5, 2012, Pages 725-730

  Yamagata, K ^a   Arai, C ^a   Sasaki, H ^a   Takeuchi, Y ^b   Onizawa, K ^a   Yanagawa, T ^a   Ishibashi, N ^a   Karube, R ^a   Shinozuka, K ^a   Hasegawa, Y ^a   Chiba, S ^a   Bukawa, H ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Mito Saiseikai Hospital   (Japan)

Author keywords

hematopoietic SCT; oral management; oral management provider; oral mucositis (OM)

Indexed keywords

ANTIBIOTIC AGENT; AZULENE SODIUM SULFATE; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FENTANYL; FLUDARABINE; IFOSFAMIDE; INDOMETACIN; INORGANIC SALT; LIDOCAINE; MELPHALAN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DIARRHEA; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOMA; MALE; MORBIDITY; MOUTH EXAMINATION; MOUTH HYGIENE; MOUTH PAIN; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; ORAL MUCOSITIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; TOOTH BRUSHING; VOMITING;

ADULT; AGED; DENTAL CARE; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMATITIS;

EID: 84860881704     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.171     Document Type: Article

References (20)

1. Bortin MM, Horowitz MM, Gale RP, Barrett AJ, Champlin RE, Dicke KA et al. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA 1992; 268: 607-612.
2. Appelbaum FR. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin 1996; 46: 142-164.
3. Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000; 110: 292-299.
4. Hwang WY, Koh LP, Ng HJ, Tan PH, Chuah CT, Fook SC et al. A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 34: 51-56.
5. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004; 4: 277-284.
6. Kostler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001; 51: 290-315.
7. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001; 19: 2201-2205.
8. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109: 820-831.
9. Da Silva Santos PS, Coracin FL, Barros JC, Dulley FL, Nunes FD, Magalhaes MG. Impact of oral care prior to HSCT on the severity and clinical outcomes of oral mucositis. Clin Transplant 2010; 25: 325-328.
10. Mori T, Hasegawa K, Okabe A, Tsujimura N, Kawata Y, Yashima T et al. Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation. Int J Hematol 2008; 88: 583-587.
11. Yamagata K, Onizawa K, Yanagawa T, Hasegawa Y, Kojima H, Nagasawa T et al. A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 237-242.
12. Yamagata K, Onizawa K, Yoshida H, Kojima Y, Koike K, Tsuchida M. Dental management of pediatric patients undergoing hematopoietic stem cell transplant. Pediatr Hematol Oncol 2006; 23: 541-548.
13. Yamagata K, Onizawa K, Yoshida H. Dental management before hematopoietic stem cell transplantation for adult and pediatric patients with hematological disease. In: Neumann KB (ed.). Hematopoietic Stem Cell Transplantation Research Advances. Nova Science Publishers: New York, 2008, pp 155-174.
14. Filicko J, Lazarus HM, Flomenberg N. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant 2003; 31: 1-10.
15. Yamagata K, Onizawa K, Yanagawa T, Takeuchi Y, Hasegawa Y, Chiba S et al. Prospective study establishing a management plan for impacted third molar in patients undergoing hematopoietic stem cell transplantation. Oral Pathol Oral Radiol Endod 2011; 111: 146-152.
16. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 2007; 15: 491-496.
17. Fliedner M, Baguet B, Blankart J, Davies M, Henriques E, Leather A et al. Palifermin for patients with haematological malignancies: shifting nursing practice from symptom relief to prevention of oral mucositis. Eur J Oncol Nurs 2007; 11 (Suppl 1): S19-S26.
18. Rapoport AP, Miller Watelet LF, Linder T, Eberly S, Raubertas RF, Lipp J et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stemcell transplants. J Clin Oncol 1999; 17: 2446-2453.
19. Peterson DE. Research advances in oral mucositis. Curr Opin Oncol 1999; 11: 261-266.
20. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 2004; 22: 1268-1275.